Results (3967)
Study on the association of uterine perforation and intrauterine device (IUD) expulsion with breastfeeding status at the time of IUD insertion and postpartum timing of IUD insertion in electronic medical record databases. A postmarketing requirement for Mirena (APEX IUD)
United States
EU PAS number:
EUPAS33461
First published:
23/04/2024
StudyFinalised
LOWER: Lomitapide Observational Worldwide Evaluation Registry (AEGR-733-025)
Argentina
Canada
France
Greece
Italy
Netherlands
United Kingdom
United States
EU PAS number:
EUPAS5326
First published:
23/04/2024
StudyOngoing
NN9535-4447 Epidemiological assessment of the risk for pancreatic cancer associated with the use of semaglutide in patients with type 2 diabetes- A cohort study based on Nordic registry data
Denmark
Norway
Sweden
EU PAS number:
EUPAS37258
First published:
23/04/2024
StudyOngoing
Cardiovascular-Renal-Metabolism comorbidity epidemiology and healthcare utilisation – Observational studies across Europe – French part of the study program (CaReMe Europe)
France
EU PAS number:
EUPAS37569
First published:
23/04/2024
StudyOngoing
Immune thrombocytopenia following vaccination with DTaP-IPV or TdaP-IPV in children
France
Germany
United Kingdom
EU PAS number:
EUPAS104290
First published:
23/04/2024
StudyFinalised
Effectiveness and Safety of Enoxaparin: Higher versus Standard Dose for Thromboprophylaxis in Patients of Varying Body Mass Index – A Retrospective Observational Cohort Study Using Real World EHR and Claims Data
Finland
EU PAS number:
EUPAS43864
First published:
23/04/2024
StudyOngoing
Epidemiology of thrombotic thrombocytopenia syndrome in integrated health-care database in England Secondary data analysis using a cohort design (Epidemiology of TTS)
United Kingdom
EU PAS number:
EUPAS103927
First published:
23/04/2024
StudyFinalised
A national, multicenter, prospective, single-arm registry PASS of pulmonary hypertension patients treated with Riociguat (Adempas®) in China (MK-4836-001) (EXPERT China)
China
EU PAS number:
EUPAS39007
First published:
23/04/2024
StudyFinalised
Active surveillance of overdose with a prolonged-release formulation of tramadol/paracetamol. The PICS study.
Czechia
Hungary
Poland
Portugal
Romania
Slovakia
Slovenia
EU PAS number:
EUPAS39805
First published:
23/04/2024
StudyOngoing
Spanish and Irish study of lithium toxicity and extracorporeal removal (SILITOX Study)
Ireland
Spain
EU PAS number:
EUPAS103542
First published:
23/04/2024
StudyFinalised
Avelumab in real-world treatment of urothelial cancer – The AVENUE NIS
Germany
Russian Federation
Spain
Switzerland
EU PAS number:
EUPAS42413
First published:
23/04/2024
StudyOngoing
Real-world use of enfortumab vedotin for the treatment of patients with locally advanced or metastatic urothelial cancer previously treated with chemotherapy and immunotherapy: a multicenter, retrospective, non-interventional study in France
France
EU PAS number:
EUPAS105591
First published:
23/04/2024
StudyPlanned
Enfortumab vedotin for the treatment of patients with locally advanced or metastatic urothelial cancer previously treated with chemotherapy and immunotherapy: a multicenter, non-interventional study in Italy (EVIDENCE)
Italy
EU PAS number:
EUPAS107848
First published:
23/04/2024
StudyPlanned
An international disease registry collecting data on manifestations, interventions and outcomes in patients with tuberous sclerosis complex - TOSCA
Australia
Austria
Belgium
China
Denmark
Estonia
France
Germany
Greece
Israel
Italy
Japan
Korea, Republic of
Latvia
Lithuania
Netherlands
Norway
Poland
Portugal
Romania
Russian Federation
Slovakia
Slovenia
South Africa
Spain
Sweden
Taiwan
Thailand
Türkiye
United Kingdom
EU PAS number:
EUPAS3247
First published:
23/04/2024
StudyFinalised
PCSCVM003617/ A Real-World Database Study of Canagliflozin Utilization in Type 1 Diabetes Patients Over Time among European Countries
Belgium
Italy
Spain
United Kingdom
EU PAS number:
EUPAS47585
First published:
23/04/2024
StudyPlanned
PRospective obsErvational Study to quantify thE buRden of illness of Vasospasm and delayed cErebral ischaemia (PRESERVE)
France
EU PAS number:
EUPAS48706
First published:
23/04/2024
StudyFinalised
Impact of the 2016 Nice terrorist attack on mental health service utilization in children and adolescents: Protocol for the PEDIMPACT Study
France
EU PAS number:
EUPAS43738
First published:
23/04/2024
StudyPlanned
Risk of suicide attempt and suicide associated with benzodiazepine: a nationwide case crossover study (R.SUB)
France
EU PAS number:
EUPAS48070
First published:
23/04/2024
StudyFinalised
A Phase I trial to investigate the effect of nintedanib on the pharmacokinetics of a combination of ethinylestradiol and levonorgestrel in female patients with Systemic Sclerosis associated Interstitial Lung Disease (SSc-ILD) (1199-0340)
Belgium
France
Germany
Netherlands
Portugal
Spain
EU PAS number:
EUPAS40026
First published:
23/04/2024
StudyFinalised
REG-501: A Registry of Patients with β-Thalassemia Treated with Betibeglogene Autotemcel
Germany
EU PAS number:
EUPAS36487
First published:
23/04/2024
StudyOngoing
Dynamics of prescription drug use, diagnoses and health care utilization after community managed SARS-CoV-2 infection
Denmark
EU PAS number:
EUPAS37658
First published:
23/04/2024
StudyFinalised
COVID-19 International Drug Pregnancy Registry (COVID-PR)
Australia
Bulgaria
Canada
Croatia
Cyprus
Czechia
Denmark
Germany
Hong Kong
Italy
Japan
Korea, Republic of
Malaysia
New Zealand
Poland
Romania
Singapore
South Africa
United Kingdom
United States
EU PAS number:
EUPAS42517
First published:
23/04/2024
StudyOngoing
Epidemiological study of COVID-19 among hospital employees: extension study of the ‘CovidPreventMainz’ (CPM) study (CPMprevac)
Germany
EU PAS number:
EUPAS37174
First published:
23/04/2024
StudyOngoing
Systemic glucocorticoids in the treatment of COVID-19 and risks of adverse outcomes in COVID-19 patients in the primary and secondary care setting (Corticosteroids in COVID19)
Belgium
France
Germany
Italy
Spain
United Kingdom
EU PAS number:
EUPAS38759
First published:
23/04/2024
StudyFinalised
A cohort study with a nested case control analysis on the association between acid-suppressing drugs and seizures using THIN database in the UK (Acid suppressing Drug Seizure Epidemiology Study)
Spain
EU PAS number:
EUPAS17954
First published:
23/04/2024
StudyFinalised
Use of non-steroidal anti-inflammatory drugs and clinical outcome of COVID-19: a Danish nationwide cohort study (NSAID COVID-19)
Denmark
EU PAS number:
EUPAS34734
First published:
23/04/2024
StudyOngoing
Retrospective non-interventional study of stiripentol use in Dravet patients in the USA (Retrospective US Study - STP228)
United States
EU PAS number:
EUPAS107005
First published:
23/04/2024
StudyOngoing
A Retrospective Database Study to Evaluate Rates of Influenza and Related Diagnoses between Patients Treated with Tofacitinib and Other Systemic Therapies within Cohorts of RA, PsA, and UC Patients: A Post-Authorization Safety Study of Tofacitinib
United States
EU PAS number:
EUPAS39242
First published:
23/04/2024
StudyFinalised
Observational study on persistent allergic rhinitis patients to evaluate effectiveness of Dymista® nasal spray in daily practice
Austria
Ireland
Sweden
EU PAS number:
EUPAS22774
First published:
23/04/2024
StudyFinalised
Study of the safety and tolerability of STALORAL® Birch and STALORAL® Birch/Alder/Hazel with a maximum dose of 300 IR daily in routine application in adults (GO FOR 300)
Germany
Switzerland
EU PAS number:
EUPAS43255
First published:
23/04/2024
StudyOngoing
Study of the safety and tolerability of ORYLMYTE in routine practice in adolescents and adults (VORAN)
Germany
EU PAS number:
EUPAS44205
First published:
23/04/2024
StudyOngoing
Drug utilisation and incident rates of adverse events in children with sialorrhoea who are treated with glycopyrronium (Glyco Sialorrhoea)
United Kingdom
EU PAS number:
EUPAS48222
First published:
23/04/2024
StudyFinalised
A study to assess utilisation and safety of Glycopyrronium Bromide 1mg/5ml Oral Solution as licensed for symptomatic treatment of severe sialorrhoea in children and adolescents aged 3 years and older with chronic neurological disorders in the UK
United Kingdom
EU PAS number:
EUPAS103644
First published:
23/04/2024
StudyOngoing
ACCESS template protocols for effectiveness of COVID-19 vaccines (ACCESS-effectiveness)
Belgium
Denmark
France
Italy
Netherlands
Spain
EU PAS number:
EUPAS39289
First published:
23/04/2024
StudyFinalised
The effect of mental disorders and treatment with psychotropic agents on the course of COVID-19 (COVID-19 psychotropics)
Denmark
EU PAS number:
EUPAS37790
First published:
23/04/2024
StudyOngoing
Real-world effectiveness of different COVID-19 vaccines in Spain: a cohort study based on public electronic health records (BIFAP) (effectiveness of COVID-19 vaccines in Spain)
Spain
EU PAS number:
EUPAS41134
First published:
23/04/2024
StudyFinalised
Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries, using a cohort approach in children and adults with a full primary Covid-19 vaccination regimen (Covid Vaccines Effectiveness (CoVE))
France
Italy
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS47725
First published:
23/04/2024
StudyFinalised
Natural history of coagulopathy and use of anti-thrombotic agents in COVID-19 patients and persons vaccinated against SARS-CoV-2
France
Germany
Italy
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS40414
First published:
23/04/2024
StudyFinalised
An Observational, Prospective Cohort Study to Evaluate Safety of Remsima® Subcutaneous in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis (CT-P13 4.8)
Belgium
Czechia
Finland
France
Germany
Italy
United Kingdom
EU PAS number:
EUPAS50207
First published:
23/04/2024
StudyOngoing
NON-INTERVENTIONAL STUDY TO REVIEW THE CHANGES OF DEPRESSION AFTER FIRST-YEAR OF TOFACITINIB TREATMENT IN RHEUMATOID ARTHRITIS (XELJANZ® )
Czechia
EU PAS number:
EUPAS40263
First published:
23/04/2024
StudyOngoing